All key LEAP platform members gathered to share recent progress in the field of Visceral Leishmaniasis.
In the frame of the LEAP meeting, DNDi and the LEAP gave a press conference on their new treatment option for VL:
“New treatment for kala azar, the most deadly parasitic disease after malaria. Urgent support needed for governments to roll out treatments and control disease“
Read the press release
